Weber W W, Miceli J N, Hearse D J, Drummond G S
Drug Metab Dispos. 1976 Jan-Feb;4(1):94-101.
Studies on acetylation of sulfadiazine, isoniazid, and p-aminobenzoic acid in selected lines of slow and rapid acetylator rabbits are described. Pedigree analysis of rabbits classified as slow or rapid sulfadiazine acetylators confirmed previous studies that the rate of sulfadiazine elimination (acetylation) is genetically controlled, with rapid elimination dominant over slow elimination of the drug. Pharmacokinetic studies in rabbits of specified sulfadiazine acetylator genotypes with isoniazid and p-aminobenzoic acid show that the rate of isoniazid elimination is under the same genetic control as is sulfadiazine, whereas the rate of p-aminobenzoic acid elimination is not. A new drug acetylation polymorphism, which controls the rate of enzymatic acetylation of p-aminobenzoic acid in peripheral blood cells and which is related to the sulfadiazine acetylation polymorphism, is described.
本文描述了对选定的慢乙酰化和快乙酰化品系家兔中磺胺嘧啶、异烟肼和对氨基苯甲酸乙酰化的研究。对分类为慢或快磺胺嘧啶乙酰化家兔的系谱分析证实了先前的研究,即磺胺嘧啶消除(乙酰化)速率受遗传控制,药物的快速消除对缓慢消除呈显性。对具有特定磺胺嘧啶乙酰化基因型的家兔用异烟肼和对氨基苯甲酸进行的药代动力学研究表明,异烟肼的消除速率与磺胺嘧啶受相同的遗传控制,而对氨基苯甲酸的消除速率则不受此控制。本文描述了一种新的药物乙酰化多态性,它控制外周血细胞中对氨基苯甲酸的酶促乙酰化速率,并且与磺胺嘧啶乙酰化多态性相关。